Acute hypercalcemia, pancreatic duct permeability, and pancreatitis in cats.
We investigated the effects of hypercalcemia on pancreatic duct permeability and pancreatitis in cats. Acute hypercalcemia was maintained by an infusion of calcium gluconate; controls received saline solution. Chronic hypercalcemia was maintained by diet and by vitamin D and dihydrotachysterol injections. Portal venous blood was analyzed for large dextran molecules that had been perfused through the pancreatic duct. In a separate group of hypercalcemic animals, we perfused the duct with activated pancreatic enzymes to induce acute pancreatitis. After 24 hours of hypercalcemia, dextrans were detected in the portal venous blood of 6 of 11 hypercalcemic and none of the 6 control animals (p less than 0.05). After 12 hours of hypercalcemia, dextrans were detected in all 7 hypercalcemic and 1 of 7 control animals (p less than 0.001). The degree of pancreatic inflammation was greater in the 12-hour animals than in the controls (p less than 0.001). After 14 days of hypercalcemia, however, there were no differences in dextran permeability or pancreatitis in experimental or control animals. Our results indicate that acute hypercalcemia increases the permeability of the pancreatic duct to molecules the size of pancreatic enzymes. This could be important in the pathogenesis of acute pancreatitis associated with hypercalcemic states.
Cates
M C
MC
Surgical Service, Veterans Administration Hospital, Columbia, Mo.
Singh
S M
SM
Peick
A L
AL
Harvey
M H
MH
Reber
H A
HA
D000208:Acute Disease; D000818:Animals; D002415:Cats; D002463:Cell Membrane Permeability; D002908:Chronic Disease; D003911:Dextrans / Q000097:blood; D005260:Female; D016650:Fluorescein-5-isothiocyanate / Q000031:analogs & derivatives*; D005452:Fluoresceins; D006934:Hypercalcemia / Q000503:physiopathology*; D008297:Male; D010183:Pancreatic Ducts / Q000503:physiopathology*; D010195:Pancreatitis / Q000503:physiopathology*
D003911:Dextrans; D005452:Fluoresceins; C015219:fluorescein isothiocyanate dextran; D016650:Fluorescein-5-isothiocyanate